Patients diagnosed with Notalgia paresthetica and who received neural therapy within the last year were retrospectively screened. In the evaluations before treatment and at the 3rd month after treatment; Numerical rating scale for pain, PainDETECT questionnaire for neuropathic pain, SF-12 for quality of life and 5-D itch scale for itch level were used.
Study Type
OBSERVATIONAL
Enrollment
12
The injection was prepared using a solution of lidocaine 2% and saline 0.9%. A 0.4% lidocaine solution was prepared by diluting 1 cc of lidocaine with 4 cc of saline.
University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital
Istanbul, Turkey (Türkiye)
Numeric Rating Scale for Pain
A scale between 0 and 10 was used to question the pain level.
Time frame: 12 weeks after treatment
PainDETECT Questionnaire for assessing Neuropathic pain
The questionnaire consists of 9 items and is completed by the patient (no clinical examination is required)\[1\]\[3\]. There are 7 weighted sensory descriptor items (never to very strongly) and 2 items relating to spatial and temporal pain characteristics\[3\]. A total score of 19 or more is indicative of likely neuropathic pain.
Time frame: 12 weeks after treatment
Short Form-12 for Quality of life
The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure.
Time frame: 12 weeks after treatment
5-D Itch Scale
The 5-D itch scale is a 5-domain disease-specific instrument evaluating the duration, degree (severity), direction (improving, unaltered or worsening), disability (impact on sleep, leisure/social, housework/errands and school/work activities) and distribution (body part affected)
Time frame: 12 weeks after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.